BRUNO, WILLIAM
 Distribuzione geografica
Continente #
EU - Europa 8.762
NA - Nord America 1.207
AS - Asia 1.037
Continente sconosciuto - Info sul continente non disponibili 218
SA - Sud America 100
AF - Africa 15
OC - Oceania 2
Totale 11.341
Nazione #
IT - Italia 8.550
US - Stati Uniti d'America 1.127
SG - Singapore 381
CN - Cina 235
VN - Vietnam 179
BD - Bangladesh 147
FR - Francia 71
BR - Brasile 59
FI - Finlandia 37
CA - Canada 36
DE - Germania 28
HK - Hong Kong 23
JP - Giappone 21
AR - Argentina 18
GB - Regno Unito 15
NL - Olanda 12
CH - Svizzera 11
CO - Colombia 8
IN - India 8
MX - Messico 8
HN - Honduras 6
IQ - Iraq 6
JM - Giamaica 6
RU - Federazione Russa 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
ES - Italia 5
GT - Guatemala 5
ID - Indonesia 5
SA - Arabia Saudita 5
LT - Lituania 4
NI - Nicaragua 4
PL - Polonia 4
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
PE - Perù 2
PK - Pakistan 2
TR - Turchia 2
UA - Ucraina 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AG - Antigua e Barbuda 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
IE - Irlanda 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MQ - Martinica 1
MW - Malawi 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 11.123
Città #
Genova 4.074
Genoa 2.825
Rapallo 794
Vado Ligure 613
San Jose 232
Singapore 176
Ashburn 170
Council Bluffs 76
Lauterbourg 63
Beijing 51
Hanoi 51
Ho Chi Minh City 47
New York 43
Helsinki 34
Milan 33
Bordighera 27
Frankfurt am Main 23
Los Angeles 23
Rome 22
Hong Kong 21
Tokyo 15
Buffalo 14
Phoenix 14
Santa Clara 14
Boardman 11
Chicago 11
Dallas 11
Houston 9
Philadelphia 9
São Paulo 9
Atlanta 8
San Francisco 8
Zurich 8
Bologna 7
Haiphong 7
Louisville 7
Montreal 7
Naples 7
Tianjin 7
London 6
Amsterdam 5
Brasília 5
Charlotte 5
Columbus 5
Da Nang 5
Mexico City 5
Newark 5
Baghdad 4
Bari 4
Biên Hòa 4
Can Tho 4
Detroit 4
Guatemala City 4
Lake Worth 4
Land O' Lakes 4
Managua 4
Miami 4
Minneapolis 4
Monroe 4
North Bergen 4
Ocala 4
San Antonio 4
Toronto 4
Van Nuys 4
Vienna 4
Augusta 3
Brooklyn 3
City of London 3
Cleveland 3
Curitiba 3
Denver 3
Florence 3
Lappeenranta 3
Las Vegas 3
Marseille 3
North Charleston 3
Pasadena 3
Port of Spain 3
Prague 3
Queens 3
Rio de Janeiro 3
Riyadh 3
Rudolfstetten 3
Salt Lake City 3
San José 3
San Pedro Sula 3
Warsaw 3
Addis Ababa 2
Albuquerque 2
Antioch 2
Asunción 2
Athens 2
Bakersfield 2
Baku 2
Borgomanero 2
Boston 2
Brantford 2
Brugherio 2
Brunswick 2
Buenos Aires 2
Totale 9.786
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 264
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 250
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 247
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 237
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 235
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 227
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 222
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 222
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 221
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 220
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 220
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT 214
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 212
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 204
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 203
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 198
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 195
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 192
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 192
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 184
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene 182
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 181
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 178
Identification, genetic testing, and management of hereditary melanoma 175
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 170
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 169
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 168
A case of four synchronous cutaneous melanomas: Melanocortin 1 receptor polymorphisms and excessive sun exposure 167
Communication of Clinically Useful Next-Generation Sequencing Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure? 166
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 165
Current State of Target Treatment in BRAF Mutated Melanoma 165
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 164
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 164
Signs and genetics of rare cancer syndromes with gastroenterological features 160
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 160
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 159
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 159
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 158
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 158
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 150
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. 149
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 146
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 143
Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation 141
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 139
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations 136
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 135
Novel MC1R variants in Ligurian melanoma patients and controls 135
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. 132
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. 131
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 128
Selection criteria for genetic assessment of patients with familial melanoma 124
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 121
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting 120
Novel MC1R variants and phenotypic expression of red hair in Ligurian melanoma patients and controls. 114
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families 114
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma 112
Skin examination behavior: The role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination 109
Melanoma risk factors, perceived threat and intentional tanning: An international online survey 109
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy 107
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 101
Multiple primary melanoma (MPM) as a valid criterion for genetic assessment : an Italian IMI multi-center study 96
Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing 93
Predictors of sun protection behaviors and severe sunburn in an international online study 88
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 84
Molecular Assessment in Patients with Melanoma: When and Why? 77
Definitions of genetic testing in Italian legal documents 76
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 74
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 73
Seven Synchronous Primary Melanomas on the Back 73
A Glance at Molecular Advances in Cancer Genetics: A Baffling Puzzle Still to Be Solved 67
Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges 60
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer 55
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomes 55
Special Issue “Molecular Advances in Cancer Genetics 3.0” 25
Joint contribution of MC1R and MITF alleles to melanoma risk in the age of polygenic risk scores 8
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 Patients 7
Special Issue "Molecular Advances in Cancer Genetics 3.0" 7
Totale 11.341
Categoria #
all - tutte 38.974
article - articoli 36.989
book - libri 0
conference - conferenze 1.625
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 360
Totale 77.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022693 0 0 62 78 35 63 48 165 54 72 32 84
2022/2023960 103 78 11 100 195 115 3 72 149 5 115 14
2023/2024580 21 54 8 70 33 105 35 51 35 22 39 107
2024/20251.613 36 101 61 130 188 159 181 284 61 90 131 191
2025/20263.411 323 113 542 232 372 236 407 128 270 308 269 211
2026/2027533 277 114 142 0 0 0 0 0 0 0 0 0
Totale 11.341